Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Visual Inspection of Transdermal Patches

Posted on By

SOP for Visual Inspection of Transdermal Patches

Standard Operating Procedure for Visual Inspection of Transdermal Patches

1) Purpose

To define procedures for visually inspecting transdermal patches to ensure they meet quality standards and specifications before release for packaging.

2) Scope

This SOP applies to the quality control department responsible for conducting visual inspections of transdermal patches during the production process.

3) Responsibilities

3.1 Quality Control Inspector: Perform visual inspections according to defined procedures.
3.2 Production Supervisor: Ensure transdermal patches are presented for inspection in a timely manner.
3.3 QA Personnel: Review and approve visual inspection procedures and reports.
3.4 Production Operators: Assist in preparing and handling transdermal patches during inspection.

See also  SOP for Leak Testing of Transdermal Patch Packages

4) Procedure

4.1 Preparation:

4.1.1 Verify availability of transdermal patches for inspection with correct batch documentation.

4.1.2 Prepare inspection area with adequate lighting and magnification tools if required.

4.2 Inspection Process:

4.2.1 Retrieve samples of transdermal patches from production at predefined intervals.

4.2.2 Examine each patch for visual defects such as discoloration, cracks, tears, or foreign particles.

4.2.3 Compare patches against approved specifications and artwork.

4.3 Defect Identification:

4.3.1 Document any defects found during inspection and classify them based on severity and impact on product quality.

4.3.2 Notify production personnel of any deviations from quality standards for immediate corrective action.

See also  SOP for Labeling of Transdermal Patches

4.4 Re-inspection:

4.4.1 Re-inspect patches that have undergone rework or repair to ensure defects have been addressed.

4.4.2 Record re-inspection findings and obtain approval before releasing patches for further processing.

4.5 Documentation:

4.5.1 Maintain detailed records of visual inspection activities, including inspection reports, photographs of defects, and approvals.

4.5.2 Archive inspection records in accordance with document control procedures and regulatory requirements.

4.6 Final Approval:

4.6.1 QA personnel review inspection reports and approve patches for packaging based on compliance with specifications.

4.6.2 Release inspected batches for packaging and further processing.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QA: Quality Assurance

See also  SOP for Out of Specification (OOS) Handling in Transdermal Patches Production

6) Documents, if any

Visual Inspection Checklists
Visual Inspection Reports
Batch Production Records

7) Reference, if any

USP General Chapter 905: Uniformity of Dosage Units
ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

8) SOP Version

Version 1.0

Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

Post navigation

Previous Post: SOP for Packaging of MDIs
Next Post: SOP for Analytical Method Development for Lotions

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version